2025年医保商保“双目录”公布——医保目录新增药品114种，50种为1类创新药

Core Insights - The National Healthcare Security Administration and the Ministry of Human Resources and Social Security announced the new National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog (2025) and the Commercial Health Insurance Innovative Drug Catalog (2025), which will be implemented nationwide starting January 1, 2026 [1] Group 1: National Basic Medical Insurance Drug Catalog - The updated National Medical Insurance Drug Catalog adds 114 new drugs, including 50 first-class innovative drugs, while removing 29 drugs that are either not clinically available or can be better replaced by other medications [1] - After the adjustments, the total number of drugs in the catalog increases to 3,253, comprising 1,857 Western medicines and 1,396 traditional Chinese medicines, significantly enhancing coverage for key areas such as oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications [1] Group 2: Commercial Health Insurance Innovative Drug Catalog - The inaugural Commercial Health Insurance Innovative Drug Catalog includes 19 drugs, which complements the basic medical insurance, laying a foundation for the differentiated development of commercial insurance and basic medical insurance, and establishing a multi-tiered medical security system [1]